Literature DB >> 26536300

Magnetic-Responsive Release Controlled by Hot Spot Effect.

Eduardo Guisasola1, Alejandro Baeza1, Marina Talelli1, Daniel Arcos1, María Moros2,3, Jesús M de la Fuente4, María Vallet-Regí1.   

Abstract

Magnetically triggered drug delivery nanodevices have attracted great attention in nanomedicine, as they can feature as smart carriers releasing their payload at clinician's will. The key principle of these devices is based on the properties of magnetic cores to generate thermal energy in the presence of an alternating magnetic field. Then, the temperature increase triggers the drug release. Despite this potential, the rapid heat dissipation in living tissues is a serious hindrance for their clinical application. It is hypothesized that magnetic cores could act as hot spots, this is, produce enough heat to trigger the release without the necessity to increase the global temperature. Herein, a nanocarrier has been designed to respond when the temperature reaches 43 °C. This material has been able to release its payload under an alternating magnetic field without the need of increasing the global temperature of the environment, proving the efficacy of the hot spot mechanism in magnetic-responsive drug delivery devices.

Mesh:

Substances:

Year:  2015        PMID: 26536300     DOI: 10.1021/acs.langmuir.5b03470

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  22 in total

Review 1.  Mesoporous silica nanoparticles in nanomedicine applications.

Authors:  Miguel Manzano; María Vallet-Regí
Journal:  J Mater Sci Mater Med       Date:  2018-05-08       Impact factor: 3.896

2.  Chitosan-Gated Magnetic-Responsive Nanocarrier for Dual-Modal Optical Imaging, Switchable Drug Release, and Synergistic Therapy.

Authors:  Hui Wang; Qingxin Mu; Richard Revia; Kui Wang; Xuezhe Zhou; Peter J Pauzauskie; Shuiqin Zhou; Miqin Zhang
Journal:  Adv Healthc Mater       Date:  2017-01-25       Impact factor: 9.933

Review 3.  Use of magnetic fields and nanoparticles to trigger drug release and improve tumor targeting.

Authors:  Jessica F Liu; Bian Jang; David Issadore; Andrew Tsourkas
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-06-26

Review 4.  Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?

Authors:  María Vallet-Regí; Ferdi Schüth; Daniel Lozano; Montserrat Colilla; Miguel Manzano
Journal:  Chem Soc Rev       Date:  2022-07-04       Impact factor: 60.615

5.  A MOF-based carrier for in situ dopamine delivery.

Authors:  Alessandra Pinna; Raffaele Ricco'; Rossana Migheli; Gaia Rocchitta; Pier Andrea Serra; Paolo Falcaro; Luca Malfatti; Plinio Innocenzi
Journal:  RSC Adv       Date:  2018-07-18       Impact factor: 4.036

Review 6.  Harnessing the Therapeutic Potential of Extracellular Vesicles for Biomedical Applications Using Multifunctional Magnetic Nanomaterials.

Authors:  Letao Yang; Kapil D Patel; Christopher Rathnam; Ramar Thangam; Yannan Hou; Heemin Kang; Ki-Bum Lee
Journal:  Small       Date:  2022-02-08       Impact factor: 15.153

7.  Bacteria as Nanoparticles Carrier for Enhancing Penetration in a Tumoral Matrix Model.

Authors:  Víctor M Moreno; Elena Álvarez; Isabel Izquierdo-Barba; Alejandro Baeza; Juana Serrano-Lopez; María Vallet-Regí
Journal:  Adv Mater Interfaces       Date:  2020-04-21       Impact factor: 6.147

Review 8.  Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: an update.

Authors:  Rafael R Castillo; Daniel Lozano; Blanca González; Miguel Manzano; Isabel Izquierdo-Barba; María Vallet-Regí
Journal:  Expert Opin Drug Deliv       Date:  2019-04-22       Impact factor: 6.648

9.  Ultrasound responsive mesoporous silica nanoparticles for biomedical applications.

Authors:  Miguel Manzano; María Vallet-Regí
Journal:  Chem Commun (Camb)       Date:  2019-02-28       Impact factor: 6.222

Review 10.  Stimuli-Responsive Iron Oxide Nanotheranostics: A Versatile and Powerful Approach for Cancer Therapy.

Authors:  Morgan E Lorkowski; Prabhani U Atukorale; Ketan B Ghaghada; Efstathios Karathanasis
Journal:  Adv Healthc Mater       Date:  2020-11-23       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.